Department of Gastroenterology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Department of Cardiology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Front Immunol. 2023 Jan 4;13:1003419. doi: 10.3389/fimmu.2022.1003419. eCollection 2022.
Colorectal cancer (CRC) ranks second for mortality and third for morbidity among the most commonly diagnosed cancers worldwide. We aimed to investigate the heterogeneity and convergence of tumor microenvironment (TME) in CRC.
We analyzed the single-cell RNA sequencing data obtained from the Gene Expression Omnibus (GEO) database and identified 8 major cell types and 25 subgroups derived from tumor, para-tumor and peripheral blood.
In this study, we found that there were significant differences in metabolic patterns, immunophenotypes and transcription factor (TF) regulatory patterns among different subgroups of each major cell type. However, subgroups manifested similar lipid metabolic patterns, immunosuppressive functions and TFs module at the end of the differentiation trajectory in CD8+ T cells, myeloid cells and Fibroblasts. Meanwhile, TFs regulated lipid metabolism and immunosuppressive ligand-receptor pairs were detected by tracing the differentiation trajectory. Based on the cell subgroup fractions calculated by CIBERSORTx and bulk RNA-sequencing data from The Cancer Genome Atlas (TCGA), we constructed an immune risk model and clinical risk model of CRC which presented excellent prognostic value.
This study identified that the differentiation was accompanied by remodeling of lipid metabolism and suppression of immune function, which suggest that lipid remodeling may be an important trigger of immunosuppression. More importantly, our work provides a new perspective for understanding the heterogeneity and convergence of the TME and will aid the development of prognosis and immunotherapies of CRC patients.
结直肠癌(CRC)是全球最常见的癌症之一,其死亡率排名第二,发病率排名第三。我们旨在研究 CRC 肿瘤微环境(TME)的异质性和趋同。
我们分析了从基因表达综合数据库(GEO)获得的单细胞 RNA 测序数据,并确定了 8 种主要细胞类型和 25 个源自肿瘤、肿瘤旁和外周血的亚群。
在这项研究中,我们发现不同主要细胞类型的每个亚群之间存在代谢模式、免疫表型和转录因子(TF)调控模式的显著差异。然而,在 CD8+T 细胞、髓样细胞和成纤维细胞的分化轨迹的末端,亚群表现出相似的脂质代谢模式、免疫抑制功能和 TF 调节模块。同时,通过追踪分化轨迹检测到 TF 调节脂质代谢和免疫抑制配体-受体对。基于 CIBERSORTx 计算的细胞亚群分数和 TCGA 中的批量 RNA-seq 数据,我们构建了 CRC 的免疫风险模型和临床风险模型,它们表现出优异的预后价值。
本研究表明,分化伴随着脂质代谢和免疫功能抑制的重塑,提示脂质重塑可能是免疫抑制的重要触发因素。更重要的是,我们的工作为理解 TME 的异质性和趋同提供了新的视角,并将有助于 CRC 患者的预后和免疫治疗的发展。